Alzheimer's disease (AD) is the most common cause of dementia associated with a
progressive neurodegenerative disorder, with a prevalence of 44 million people throughout …

This review examines key pharmacological strategies that have been clinically studied for
the primary or secondary prevention of Alzheimer's disease. Much information …

One of the major puzzles in medical research and public health systems worldwide is
Alzheimer's disease (AD), reaching nowadays a prevalence near 50 million people. This is a …

Alzheimer's disease (AD) is a disorder that causes degeneration of the cells in the brain and
it is the main cause of dementia, which is characterized by a decline in thinking and …

Objectives To assess whether previous research on purported risk or protective factors for
Alzheimer's disease (AD) and cognitive decline is of sufficient strength to warrant specific …

Alzheimer's disease (AD) is a chronic dysfunction of neurons in the brain leading to
dementia. It is characterized by gradual mental failure, abnormal cognitive functioning …

Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …

Alzheimer's disease (AD) is the most common form of dementia. AD initially targets memory
and progressively destroys the mind. The brain atrophies as the neocortex suffers neuronal …

Risk of developing Alzheimer's disease is increased by older age, genetic factors, and
several medical risk factors. Studies have also suggested that dietary and lifestyle factors …

Alzheimer's disease (AD) is characterized by dysfunctional intracellular and extracellular
biochemical processes that result in neuron death. This article summarizes hypotheses …